| __timestamp | Arrowhead Pharmaceuticals, Inc. | MiMedx Group, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 105558000 |
| Thursday, January 1, 2015 | 382000 | 167094000 |
| Friday, January 1, 2016 | 158333 | 212608000 |
| Sunday, January 1, 2017 | 31407709 | 285920000 |
| Monday, January 1, 2018 | 16142321 | 322725000 |
| Tuesday, January 1, 2019 | 168795577 | 256174000 |
| Wednesday, January 1, 2020 | 87992066 | 208904000 |
| Friday, January 1, 2021 | 138287000 | 215332000 |
| Saturday, January 1, 2022 | 232810000 | 219525000 |
| Sunday, January 1, 2023 | 240735000 | 266843000 |
| Monday, January 1, 2024 | 3551000 |
In pursuit of knowledge
In the ever-evolving landscape of biotechnology, understanding financial health is crucial. This analysis delves into the gross profit trends of Arrowhead Pharmaceuticals, Inc. and MiMedx Group, Inc. from 2014 to 2023. Arrowhead Pharmaceuticals has shown a remarkable growth trajectory, with gross profits surging from a modest $175,000 in 2014 to an impressive $240 million in 2023. This represents a staggering increase of over 137,000%. Meanwhile, MiMedx Group, Inc. has maintained a steady performance, with gross profits peaking at $323 million in 2018 before stabilizing around $267 million in 2023. Despite missing data for 2024, the trends highlight Arrowhead's aggressive growth strategy, while MiMedx's consistency underscores its resilience in the market. These insights provide a window into the strategic maneuvers of these companies in the competitive biotech sector.
Gross Profit Analysis: Comparing Eli Lilly and Company and MiMedx Group, Inc.
Gross Profit Trends Compared: Gilead Sciences, Inc. vs MiMedx Group, Inc.
Gross Profit Comparison: Walgreens Boots Alliance, Inc. and MiMedx Group, Inc. Trends
Gross Profit Trends Compared: Jazz Pharmaceuticals plc vs MiMedx Group, Inc.
Corcept Therapeutics Incorporated and Arrowhead Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? MorphoSys AG or Arrowhead Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing HUTCHMED (China) Limited and MiMedx Group, Inc.
Gross Profit Trends Compared: Arrowhead Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. vs MiMedx Group, Inc.: Examining Key Revenue Metrics
Arrowhead Pharmaceuticals, Inc. vs Evotec SE: A Gross Profit Performance Breakdown
Gross Profit Comparison: Amphastar Pharmaceuticals, Inc. and MiMedx Group, Inc. Trends
Who Generates Higher Gross Profit? Evotec SE or MiMedx Group, Inc.